Skip to main content
G2GBIO, Inc. logo

G2GBIO, Inc. — Investor Relations & Filings

Ticker · 456160 ISIN · KR7456160001 KO Manufacturing
Filings indexed 89 across all filing types
Latest filing 2026-05-22 Director's Dealing
Country KR South Korea
Listing KO 456160

About G2GBIO, Inc.

https://www.g2gbio.com/

G2GBIO, Inc. is a biotechnology company specializing in sustained-release pharmaceuticals through its proprietary drug delivery system platform. The company's core technology, InnoLAMP (Innovative Long-Acting MicroParticle), is used to develop long-acting injectable microspheres that provide a controlled, extended release of therapeutic agents. This platform aims to improve treatment efficacy and patient compliance for chronic diseases by reducing dosing frequency. G2GBIO's research and development pipeline is focused on creating long-acting formulations for conditions including Alzheimer's disease, Type 2 diabetes, schizophrenia, and post-operative pain. The company also develops specialized applications for targeted drug delivery in areas such as oncology.

Recent filings

Filing Released Lang Actions
[기재정정]임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 93% confidence The document is a Korean regulatory filing titled “임원ㆍ주요주주 특정증권등 소유상황보고서” (Executive and Major Shareholder Specific Securities Ownership Report) and is a correction (“정정신고”) to a previously submitted insider ownership report. It details share ownership changes by a company executive, including acquisition dates, amounts, and revised totals. This matches the definition for Director’s Dealing (insider transactions by directors/executives). It is not a general financial report, dividend notice, or capital change announcement. Therefore, it is classified as DIRS.
2026-05-22 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 95% confidence The document is a Korean regulatory filing titled “임원ㆍ주요주주 특정증권등 소유상황보고서,” which translates to a report on securities ownership by executives and major shareholders. It details an executive’s share transactions, ownership percentages, and changes in holdings. This corresponds exactly to insider transaction disclosures by directors/major shareholders. Therefore, it is classified as a Director’s Dealing report (DIRS).
2026-05-21 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 95% confidence The document is a statutory insider holdings report (‘임원ㆍ주요주주 특정증권등 소유상황보고서’) detailing share ownership and changes by a company executive. It is not a general financial report or AGM material but a report of personal securities transactions by a director/executive. This corresponds to a Director’s Dealing filing.
2026-05-21 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 85% confidence The document is a Form 6.1 “임원ㆍ주요주주 특정증권등 소유상황보고서”, a standard Korean insider/major‐shareholder securities holdings report listing personal share ownership, changes (e.g., option exercises), and confirming no omissions. This aligns with insider share transaction reporting by directors/executives, matching the “Director's Dealing” category rather than a general major‐shareholding threshold notice, annual report, or announcement of a broader regulatory filing.
2026-05-21 Korean
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 96% confidence The document is titled 분기보고서 (Quarterly Report) covering the period January 1 to March 31, 2026 (제10기 1분기). It contains comprehensive company overview, business contents, detailed financial tables (sales, materials, assets, liabilities, etc.), management discussion, and risk disclosures. It is a full interim/quarterly report with substantive financial data, matching the definition of an Interim/Quarterly Report (Code: IR). Q1 2026
2026-05-15 Korean
기업설명회(IR)개최
Investor Presentation Classification · 85% confidence The document is an announcement of a scheduled investor relations presentation (IR meeting), detailing date, time, location, participants, purpose, content, and posting of IR materials on the exchange’s website. It is clearly an investor presentation event notice, fitting the “Investor Presentation” category rather than a full financial report or regulatory filing.
2026-04-14 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.